100% Quality Guarantee
PhD-Level Technical Support
Human PD1/PDL1 Inhibitor Screening Assay Kit
Key Features

Human PD1/PDL1 Inhibitor Screening Assay Kit (AEFI00203)

SKU AEFI00203
Product Type ELISA Kit
Size 96 Assays
Sensitivity 0.188ng/ml
Range 0.313-20ng/ml
ELISA Type Competitive
Reactivity Human
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human PD1/PDL1 Inhibitor Screening Assay Kit

The Human PD-1/PD-L1 Inhibitor Screening Assay Kit from Assay Genie is a cutting-edge tool for researchers studying immune checkpoint inhibitors in the context of cancer immunotherapy. This kit allows for the accurate and efficient screening of potential inhibitors targeting the PD-1/PD-L1 pathway, crucial in regulating immune responses, tumor evasion, and immune tolerance.With its high sensitivity and specificity, researchers can confidently assess the activity and efficacy of potential inhibitors, facilitating the development of novel therapeutic strategies for cancer treatment.

The kit is suitable for use with a variety of sample types, including serum, plasma, and cell culture supernatants, providing flexibility for different experimental setups.Don't miss out on the opportunity to advance your research in cancer immunotherapy with the Human PD-1/PD-L1 Inhibitor Screening Assay Kit from Assay Genie. Order yours today and take the next step towards developing innovative treatments for cancer.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose